Citadel Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.1M | Sell |
|
|||||
|
2025
Q1 | $43.9M | Buy |
|
|||||
|
2024
Q4 | $52.6M | Sell |
|
|||||
|
2024
Q3 | $62.5M | Buy |
|
|||||
|
2024
Q2 | $28.7M | Sell |
|
|||||
|
2024
Q1 | $72.1M | Sell |
|
|||||
|
2023
Q4 | $121M | Buy |
|
|||||
|
2023
Q3 | $30.9M | Sell |
|
|||||
|
2023
Q2 | $33.8M | Sell |
|
|||||
|
2023
Q1 | $84.5M | Buy |
|
|||||
|
2022
Q4 | $24.4M | Buy |
|
|||||
|
2022
Q3 | $20.4M | Sell |
|
|||||
|
2022
Q2 | $72.5M | Buy |
|
|||||
|
2022
Q1 | $17.5M | Sell |
|
|||||
|
2021
Q4 | $19M | Sell |
|
|||||
|
2021
Q3 | $28.7M | Sell |
|
|||||
|
2021
Q2 | $30.1M | Buy |
|
|||||
|
2021
Q1 | $22.5M | Buy |
|
|||||
|
2020
Q4 | $13.3M | Sell |
|
|||||
|
2020
Q3 | $20.3M | Buy |
|
|||||
|
2020
Q2 | $3.1M | Sell |
|
|||||
|
2020
Q1 | $9.46M | Sell |
|
|||||
|
2019
Q4 | $22.1M | Buy |
|
|||||
|
2019
Q3 | $3.57M | Sell |
|
|||||
|
2019
Q2 | $10.6M | Sell |
|
|||||
|
2019
Q1 | $27.3M | Sell |
|
|||||
|
2018
Q4 | $37.3M | Sell |
|
|||||
|
2018
Q3 | $58M | Buy |
|
|||||
|
2018
Q2 | $37.4M | Buy |
|
|||||
|
2018
Q1 | $6.21M | Buy |
|
|||||
|
2017
Q4 | $4.87M | Sell |
|
|||||
|
2017
Q3 | $8.89M | Buy |
|
|||||
|
2017
Q2 | $5.62M | Sell |
|
|||||
|
2017
Q1 | $19.7M | Sell |
|
|||||
|
2016
Q4 | $68.8M | Buy |
|
|||||
|
2016
Q3 | $46.6M | Buy |
|
|||||
|
2016
Q2 | $5.28M | Sell |
|
|||||
|
2016
Q1 | $14.6M | Sell |
|
|||||
|
2015
Q4 | $41.2M | Buy |
|
|||||
|
2015
Q3 | $996K | Sell |
|
|||||
|
2015
Q2 | $47.4M | Buy |
|
|||||
|
2015
Q1 | $24.6M | Buy |
|
|||||
|
2014
Q4 | $12.4M | Sell |
|
|||||
|
2014
Q3 | $68.2M | Sell |
|
|||||
|
2014
Q2 | $99.2M | Buy |
|
|||||
|
2014
Q1 | $15.5M | Buy |
|
|||||
|
2013
Q4 | $9.2M | Sell |
|
|||||
|
2013
Q3 | $9.98M | Sell |
|
|||||
|
2013
Q2 | $18M | Buy |
|